Hemochromatosis mutations C282Y and H63D in 'cis' phase

被引:18
作者
Best, LG
Harris, PE
Spriggs, EL
机构
[1] Univ N Dakota, Dept Family Med, Grand Forks, ND 58201 USA
[2] Univ Manitoba, Fac Med, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Clin Chem, Hlth Sci Ctr, Winnipeg, MB, Canada
[4] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada
关键词
diagnosis; genetic screening; genetics-population; hemochromatosis; linkage disequilibrium; mutation;
D O I
10.1034/j.1399-0004.2001.600111.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Homozygosity for the C282Y mutation of the HFE gene is a highly significant risk factor for the development of hereditary hemochromatosis (HH) and the majority of patients with HH have this genotype. An Irish/Belgian female with an elevated serum ferritin level and a family history of hemochromatosis was tested for the presence of the C282Y and H63D mutations. Results of digested PCR products have shown the patient to be homozygous for C282Y mutation and heterozygous for H63D mutation. Sequencing confirmed these findings. Genotyping of the patient's offspring and husband has also indicated the inheritance of both C282Y and H63D in 'cis'. Implications of this finding are: 1) the compound heterozygous state is by far the most common, but not the universal. phase for individuals found to be heterozygous for the two mutations, C282Y and H63D, 2) the C282Y and H63D mutations in the 'cis' phase may account for some cases of questionable parentage.
引用
收藏
页码:68 / 72
页数:5
相关论文
共 29 条
[1]   Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria [J].
Adams, PC ;
Chakrabarti, S .
GASTROENTEROLOGY, 1998, 114 (02) :319-323
[2]  
Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1
[3]  
Barton JC, 1999, GENET MED, V1, P89
[4]   A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria [J].
Brissot, P ;
Moirand, R ;
Jouanolle, AM ;
Guyader, D ;
Le Gall, JY ;
Deugnier, Y ;
David, V .
JOURNAL OF HEPATOLOGY, 1999, 30 (04) :588-593
[5]  
CHU TW, 1996, PRINCIPLES PRACTICE, P2050
[6]  
Fairbanks VF, 1998, GUT, V43, P441, DOI 10.1136/gut.43.3.441
[7]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[8]   C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes [J].
Fernandez-Real, JM ;
Vendrell, J ;
Baiget, M ;
Gimferrer, E ;
Ricart, W .
DIABETES CARE, 1999, 22 (03) :525-526
[9]  
Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249
[10]   Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis [J].
Jeffrey, GP ;
Chakrabarti, S ;
Hegele, RA ;
Adams, PC .
NATURE GENETICS, 1999, 22 (04) :325-326